The recent investigation by Ahn et al. underscores the potential therapeutic utility of percutaneous transluminal venous angioplasty (PTVA) for managing neurogenic thoracic outlet syndrome (nTOS), highlighting significant symptomatic improvement through minimally invasive vascular intervention.
Surgical resection remains the cornerstone of sarcoma treatment; however, tumor involvement of major vasculature presents challenges. Multidisciplinary approaches incorporating vascular surgery have expanded feasibility of resection, yet long-term outcome data remain limited.
Arteriovenous grafts are considered for hemodialysis access in patients without a suitable vein for the creation of an arteriovenous fistula. The most commonly used synthetic polytetrafluorethylene (PTFE) graft carries a high risk of infection (6 to 29%) and limited biocompatibility. The bovine carotid artery graft (BCAG), a biological alternative, may address these limitations. This systemic review and meta-analysis compared clinical outcomes of BCAG versus PTFE grafts.
Endovascular treatment is an effective treatment option for peripheral arterial disease, which is a common disease with an increasing incidence rate. The importance of vessel preparation methods in endovascular treatment is well understood, and atherectomy, one of these methods, is frequently used to treat patients with peripheral arterial disease. In this study, we aimed to compare the primary patency rates and long-term outcomes of patients who underwent atherectomy for infrainguinal peripheral arterial disease according to lesion location.
Patients with chronic limb threatening ischaemia (CLTI) unsuitable for conventional endovascular or surgical revascularisation are treated with major amputation. Superficial venous arterialisation (SVA) presents an alternative option. No cases report success beyond 2 years.
The American Diabetes Association recommends the use of glucagon-like-peptide-1 receptor agonists (GLP1-RAs) (e.g. Ozempic) for patients with atherosclerotic cardiovascular disease, including PAD. We hypothesized increasing use of GLP1-RAs would be associated with improved outcomes after bypass.
To evaluate the long-term surgical outcomes of advanced renal cell carcinoma (RCC) with a thrombus extending into the inferior vena cava (IVC).
Behçet’s disease (BD) is a complex multi-systemic disorder characterized by recurrent oral and genital ulcers, as well as a range of other manifestations such as vascular, ocular, neurologic and gastrointestinal involvement. The clinical manifestations of BD are markedly heterogeneous and may vary significantly according to sex, ethnicity, age at disease onset, and geographic origin. Vascular involvement is also major cause of mortality and morbidity in BD. There are no specific biological, histological or imaging tests to diagnose BD.
We read with great interest the recent article by Ripepi et al.[1] titled “Open Versus Endovascular Repair of Patent Popliteal Artery Aneurysms in an Elective Setting: A Multicentre Retrospective Study with Long-Term Follow-Up” published in your esteemed journal. The study presents a valuable and comprehensive retrospective analysis comparing open surgical repair (OR) and endovascular repair (EPAR) for popliteal artery aneurysms (PAAs) in an elective setting. By evaluating both early and long-term outcomes, including primary and secondary patency, reintervention rates, and limb salvage, the authors offer important insights into treatment selection for a condition with evolving management strategies.